Your browser doesn't support javascript.
loading
Retraction notice to "Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities" [Bioorg. Med. Chem. Lett. 22(9) (2012) 3067-3071].
Chang, Minsun; Lee, Sung-Hak; Kim, Ho Jun; Koh, Jong-Sung; Kim, Aeri.
Afiliação
  • Chang M; Drug Metabolism and Pharmacokinetics Department, LG Life Sciences R&D Center, Daejeon, Republic of Korea.
  • Lee SH; Drug Metabolism and Pharmacokinetics Department, LG Life Sciences R&D Center, Daejeon, Republic of Korea.
  • Kim HJ; Drug Metabolism and Pharmacokinetics Department, LG Life Sciences R&D Center, Daejeon, Republic of Korea.
  • Koh JS; Medicinal Chemistry Department, LG Life Sciences R&D Center, Daejeon, Republic of Korea.
  • Kim A; Division of Business Development, LG Life Sciences, Seoul, Republic of Korea. Electronic address: arkim512@gmail.com.
Bioorg Med Chem Lett ; 104: 129734, 2024 05 15.
Article em En | MEDLINE | ID: mdl-38604924

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2024 Tipo de documento: Article